SCHEMBL3790047

SCHEMBL3790047

COc1cc(C(C)(C)c2cnc(SCc3c(F)cc(NC(=O)O)cc3F)n2-c2ccc(F)cc2)ccc1Cl

nearest known ligand 0.65

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 18/20 0.65
NR1H4 Q96RI1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL604632 0.92 GPBAR1 (0.62) GPBAR1NR1H4
SCHEMBL602762 0.90 GPBAR1 (0.67) GPBAR1NR1H4
SCHEMBL605076 0.89 GPBAR1 (0.62) GPBAR1NR1H4
SCHEMBL601919 0.88 GPBAR1 (0.65) GPBAR1NR1H4
SCHEMBL10274600 0.87 GPBAR1 (0.70) GPBAR1NR1H4
SCHEMBL600930 0.87 GPBAR1 (0.68) GPBAR1NR1H4
SCHEMBL603827 0.87 GPBAR1 (0.58) GPBAR1NR1H4
SCHEMBL603828 0.87 GPBAR1 (0.58) GPBAR1NR1H4
SCHEMBL13270252 0.87 GPBAR1 (0.69) GPBAR1NR1H4
SCHEMBL603325 0.86 GPBAR1 (0.71) GPBAR1NR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2396304-A1 TRIAZOLE AND IMIDAZOLE DERIVATIVES FOR USE AS TGR5 AGONISTS IN THE TREATMENT OF DIABETES AND OBESITY Exelixis, Inc. (US) 2011-12-21 EP disclosed
WO-2010093845-A1 TRIAZOLE AND IMIDAZOLE DERIVATIVES FOR USE AS TGR5 AGONISTS IN THE TREATMENT OF DIABETES AND OBESITY EXELIXIS, INC. (US) 2010-08-19 WO disclosed